Healthcare -
Biotechnology - NASDAQ - US
$ 61.53
0.457 %
$ 11.7 B
Market Cap
37.07
P/E
BMRN - STOCK-BASED COMPENSATION
Stock-based Compensation BMRN - BioMarin Pharmaceutical Inc.
207 M
LAST VALUE
2.46%
2 YEAR CAGR
6.83%
5 YEAR CAGR
12.08%
10 YEAR CAGR